Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
Riccardo Maria Inciardi, MD, PhD
The CONFIDENCE Trial: Data Insights
prof. Hiddo Heerspink
Albuminuria Change and Finerenone's Effect on CV Outcomes
Finnian R. McCausland, MD
Impact of Finerenone on eGFR Slope by Baseline Albuminuria in FINEARTS-HF
Topline Results of the CONFIDENCE Trial
Rajiv Agarwal, MBBS, MD, FASN, BRCU
Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
Jennifer B. Green, MD
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
Robert J. Mentz, MD, FHFSA, FACC, FAHA
Piotr Ponikowski, MD, PhD, FESC, FHFA
Latest Clinical Trial Outcomes and Breakthroughs for FCS
Daniel Gaudet, MD, PhD
Pam R. Taub, MD, FACC, FASPC
Remnant Cholesterol: The Missing Link in ASCVD risk
Børge G. Nordestgaard, MD, DMSc
Kausik Ray, MBChB, MD, MPhil
SHTG: Decoding the Latest Clinical Trial Outcomes
SHTG: Defining the Unmet Clinical Need
Targeting Mixed Hyperlipidemia with APOC3 Inhibition
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
APOC3 Inhibition: A Novel Approach to Lowering TGs
Shifting Treatment Paradigm in HFmrEF/HFpEF: Steroidal and Nonsteroidal MRAs
Faiez Zannad, MD, PhD
John McMurray, MD
FCS: Enhancing the Diagnosis
Loading...
We're glad to see you're enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.